Cost analysis of adrenergic receptor blockers of different brands available in India.

Dr Vaibhav Chauhan; Dr. Siddharth Banode; Dr. Ashutosh Chourishi

Volume : V, Issue : XI, November - 2016

Cost analysis of adrenergic receptor blockers of different brands available in India.

Dr Vaibhav Chauhan, Dr. Siddharth Banode, Dr. Ashutosh Chourishi

Abstract :

Background: Adrenergic receptors blockers are drugs used for various diseases like hypertension ,angina, arrthmia, migraine,benign prostatic hyperplasia, phaaeochromocytoma etc ,these medications used for a prolonged period and even sometimes lifelong medications required to treat the disease. Costly and of medications if prescribed in such cases adds to the burden of disease and may even lead to failure of compliance of therapy. Hence the study was designed to evaluate the cost of adrenergic receptor blocker drugs of different and names and to analyze price variation among various Adrenergic receptor blocker drugs available in Indian market. Methods: Prices of various drugs marketed by different companies was obtained from IDR. The variation between highest and lowest price of the same medication manufactured by various pharma companies and percentage variation in cost for ten tablets was calculated. Results: Cost analysis of adrenergic receptor blocker drugs was done. These drugs were available in the market different formulations, manufactured by different pharmaceutical companies. Percent variation in cost was found to be highest, for the drug Atenolol (815.34%) of which there were 22 ands followed by Metoprolol (580.54%), of which there were only 28 pharmaceutical ands. Lowest percent variation in cost was of pindolol (30.43%), with 2 pharmaceutical preparations. Conclusion: To increase the benefit on patients counterpart, generic drug prescribing or prescribing cheaper medications of same strength should be encouraged among practitioners.